Bipolar disorder laboratory findings

Jump to navigation Jump to search

Bipolar disorder Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Causes

Differentiating Bipolar disorder from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Bipolar I
Bipolar II
Cyclothymic Disorder
Substance/Medication-Induced Bipolar Disorder
Bipolar Disorder Due to Another Medical Condition
Unspecified Bipolar Disorder

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bipolar disorder laboratory findings On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bipolar disorder laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bipolar disorder laboratory findings

CDC on Bipolar disorder laboratory findings

Bipolar disorder laboratory findings in the news

Blogs on Bipolar disorder laboratory findings

Directions to Hospitals Treating Bipolar disorder

Risk calculators and risk factors for Bipolar disorder laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nuha Al-Howthi, MD[2]


Overview

No laboratory test is required to establish the diagnosis of bipolar disorder. However, laboratory tests can help to exclude alternative etiologies for mood symptoms. Laboratory tests may include a urine toxicology screen and a complete blood count. Fasting glucose and lipid assessments are important for establishing the presence of diabetes or hyperlipidemia.

Bipolar disorder laboratory findings

Other laboratory tests

Substance and Alcohol Screening

  • Many patients with bipolar disorder, also have high rate of substance use disorders as a result it is associated with significant morbidity and mortality.[12]

References

  1. Price AL, Marzani-Nissen GR (2012). "Bipolar disorders: a review". Am Fam Physician. 85 (5): 483–93. PMID 22534227.
  2. Price AL, Marzani-Nissen GR (2012). "Bipolar disorders: a review". Am Fam Physician. 85 (5): 483–93. PMID 22534227.
  3. Culpepper L (2014). "The diagnosis and treatment of bipolar disorder: decision-making in primary care". Prim Care Companion CNS Disord. 16 (3). doi:10.4088/PCC.13r01609. PMC 4195640. PMID 25317368.
  4. Culpepper L (2014). "The diagnosis and treatment of bipolar disorder: decision-making in primary care". Prim Care Companion CNS Disord. 16 (3). doi:10.4088/PCC.13r01609. PMC 4195640. PMID 25317368.
  5. Culpepper L (2014). "The diagnosis and treatment of bipolar disorder: decision-making in primary care". Prim Care Companion CNS Disord. 16 (3). doi:10.4088/PCC.13r01609. PMC 4195640. PMID 25317368.
  6. Krishna VN, Thunga R, Unnikrishnan B, Kanchan T, Bukelo MJ, Mehta RK; et al. (2013). "Association between bipolar affective disorder and thyroid dysfunction". Asian J Psychiatr. 6 (1): 42–5. doi:10.1016/j.ajp.2012.08.003. PMID 23380316.
  7. Krishna VN, Thunga R, Unnikrishnan B, Kanchan T, Bukelo MJ, Mehta RK; et al. (2013). "Association between bipolar affective disorder and thyroid dysfunction". Asian J Psychiatr. 6 (1): 42–5. doi:10.1016/j.ajp.2012.08.003. PMID 23380316.
  8. Culpepper L (2014). "The diagnosis and treatment of bipolar disorder: decision-making in primary care". Prim Care Companion CNS Disord. 16 (3). doi:10.4088/PCC.13r01609. PMC 4195640. PMID 25317368.
  9. Machado AC, Deguti MM, Caixeta L, Spitz M, Lucato LT, Barbosa ER (2008). "Mania as the first manifestation of Wilson's disease". Bipolar Disord. 10 (3): 447–50. doi:10.1111/j.1399-5618.2007.00531.x. PMID 18402634.
  10. Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F (2007). "[The onset of psychiatric disorders and Wilson's disease]". Encephale. 33 (6): 924–32. doi:10.1016/j.encep.2006.08.009. PMID 18789784.
  11. "HIV and psychiatric comorbidities: What do we know and what can we do?".
  12. 12.0 12.1 Kenneson A, Funderburk JS, Maisto SA (2013). "Risk factors for secondary substance use disorders in people with childhood and adolescent-onset bipolar disorder: opportunities for prevention". Compr Psychiatry. 54 (5): 439–46. doi:10.1016/j.comppsych.2012.12.008. PMID 23332720.